Back
Regeneron Pharmaceuticals Stock Price Chart
10 Stellar Stocks - get the names here
Learn their names here. FREE
Sell
42
REGN
Regeneron Pharmaceuticals
Last Price:
$696.47
Seasonality Move:
1.02%
7 Day Trial
ALL ACCESS PASS
$
7
Data Just Made Palantir Worth $200B - Is This #1 Software Company Next?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is relatively stagnant and REGN is experiencing slight buying pressure.
Regeneron Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 678.65 | Buy |
| 20-day SMA: | 686.34 | Buy |
| 50-day SMA: | 706.88 | Sell |
| 200-day SMA: | 934.23 | Sell |
| 8-day EMA: | 684.83 | Buy |
| 20-day EMA: | 688.63 | Buy |
| 50-day EMA: | 719.53 | Sell |
| 200-day EMA: | 857.17 | Sell |
Regeneron Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -6.98 | Sell |
| Relative Strength Index (14 RSI): | 51.04 | Buy |
| Chaikin Money Flow: | 103896 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (672.18 - 701.64) | Buy |
| Bollinger Bands (100): | (675.19 - 920.19) | Sell |
Regeneron Pharmaceuticals Technical Analysis
| Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 06 | 07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Regeneron Pharmaceuticals Stock
Is Regeneron Pharmaceuticals Stock a Buy?
-
Regeneron Pharmaceuticals share price is 696.02 while REGN 8-day simple moving average is 678.65, which is a Buy signal.
-
The stock price of REGN is 696.02 while Regeneron Pharmaceuticals 20-day SMA is 686.34, which makes it a Buy.
-
Regeneron Pharmaceuticals 50-day simple moving average is 706.88 while REGN share price is 696.02, making it a Sell technically.
-
REGN stock price is 696.02 and Regeneron Pharmaceuticals 200-day simple moving average is 934.23, creating a Sell signal.
REGN Technical Analysis vs Fundamental Analysis
Sell
42
Regeneron Pharmaceuticals (REGN)
is a Sell
Is Regeneron Pharmaceuticals a Buy or a Sell?
-
Regeneron Pharmaceuticals stock is rated a SellThe current Regeneron Pharmaceuticals [REGN] share price is $696.02. The Score for REGN is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
Regeneron Pharmaceuticals Stock Info
Market Cap:
76.1B
Price in USD:
696.02
Share Volume:
533.4K
Regeneron Pharmaceuticals 52-Week Range
52-Week High:
1,211.20
52-Week Low:
642.00
Sell
42
Regeneron Pharmaceuticals (REGN)
is a Sell
Regeneron Pharmaceuticals Share Price Forecast
-
What is the Regeneron Pharmaceuticals stock price today?The Regeneron Pharmaceuticals stock price is 696.02 USD today.
-
Will REGN stock go up or go down?Regeneron Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Regeneron Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Regeneron Pharmaceuticals is overvalued.
Is Regeneron Pharmaceuticals Stock a Buy?
-
Regeneron Pharmaceuticals share price is 696.02 while REGN 8-day exponential moving average is 684.83, which is a Buy signal.
-
The stock price of REGN is 696.02 while Regeneron Pharmaceuticals 20-day EMA is 688.63, which makes it a Buy.
-
Regeneron Pharmaceuticals 50-day exponential moving average is 719.53 while REGN share price is 696.02, making it a Sell technically.
-
REGN stock price is 696.02 and Regeneron Pharmaceuticals 200-day simple moving average is 857.17, creating a Sell signal.
Fundamental Analysis of Regeneron Pharmaceuticals
Is Regeneron Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.85 per share, an increase next quarter of $0.43 per share, a decrease this year of $1.83 per share, and an increase next year of $3.98 per share.
Technical Analysis of Regeneron Pharmaceuticals
Should I short Regeneron Pharmaceuticals stock?
-
REGN Moving Average Covergence Divergence (MACD) indicator is -6.98, suggesting Regeneron Pharmaceuticals is a Sell
-
Regeneron Pharmaceuticals Relative Strength Index (RSI) is 51.04, which suggest Regeneron Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Regeneron Pharmaceuticals is (672.18 - 701.64), which suggest Regeneron Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Regeneron Pharmaceuticals is (675.19 - 920.19), which suggest Regeneron Pharmaceuticals is a Sell
* Regeneron Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.